Convatec Group PLC
CTEC.LHealthcareLSEMedical Instruments & Supplies
Scan Results
Daily timeframePart of the healthcare sector, Convatec Group PLC (CTEC.L) is listed under Medical Instruments & Supplies. Valued at $3.88B, CTEC.L is a mid-cap name in its sector. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
Market Cap
$3.88B
Beta
0.78
P/E (TTM)
33.05
P/E (Fwd)
11.84
EPS (TTM)
$0.06
EPS (Fwd)
$0.17
ROE
10.9%
ROA
7.0%
Cash
$68.0M
Total Debt
$1.52B
Free CF
$241.5M
52W Change
-30.0%
Annual Financials
Cash vs Debt
On the balance sheet, CTEC.L has $68.0M in cash with $1.52B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $241.5M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 10.9%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 7.0% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $2.07B to $2.44B.
The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing CTEC.L.